Anthology
Founded 2023 · 19 employees on LinkedIn · 3 known investors
Anthology develops designer and hybrid genomes by decoding genomic "language" to engineer microbes that convert feedstocks such as sugars, plastics, and agricultural waste into products like chemicals, materials, and food ingredients. Its applications include producing functional proteins for healthy aging and GLP-1 companion foods, enzymes to improve animal health, and carbon-neutral bioproduction for a circular bioeconomy.
Investors · 3
.jpeg){kind=logo}
Frequently asked questions
- What does Anthology do?
- Anthology develops designer and hybrid genomes by decoding genomic "language" to engineer microbes that convert feedstocks such as sugars, plastics, and agricultural waste into products like chemicals, materials, and food ingredients. Its applications include producing functional proteins for healthy aging and GLP-1 companion foods, enzymes to improve animal health, and carbon-neutral bioproduction for a circular bioeconomy.
- Who are Anthology's investors?
- Anthology's investors include Juniper, The E14 Fund, The Engine Ventures.